Analysis demonstrates Michaelis-Menten approximations for drug disposition in bivalent drugs, suggesting effects of avidity on pharmacokinetics.
The Michaelis-Menten (MM) approximation of the target-mediated drug disposition (TMDD) model is often used to describe nonlinear pharmacokinetics of monoclonal antibodies, which are, however, bivalent molecules. We analyze a TMDD model for bivalent drugs by means of quasi-steady state approximations, which yield MM approximations in the limit of weak avidity (soluble targets) and strong avidity (cell surface targets), thereby providing a justification for the use of MM approximations for bivalent drugs with slow systemic clearance.
No takes yet. Share an insight, caveat, or question.
Ronny Straube (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: